SAGIMET BIOSCIENCES INC-A (SGMT) Stock Balance Sheet
NASDAQ:SGMT - Nasdaq - US7867001049 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 75.84M | 75.14M | 160.00K | 56.73M | 68.70M | |||
| Marketable Securities | 75.41M | 19.76M | 32.19M | 0.00 | N/A | |||
| Other Current Assets | 1.52M | 1.75M | 450.00K | 1.93M | 40.00K | |||
| Total Current Assets | 152.77M | 96.65M | 32.79M | 58.66M | 68.74M | |||
| Non-Current Assets | ||||||||
| PPE Net | 77.00K | 73.00K | 210.00K | 340.00K | 190.00K | |||
| Investments And Advances | 7.41M | N/A | 30.00K | 30.00K | 30.00K | |||
| Total Non-Current Assets | 7.49M | 73.00K | 240.00K | 370.00K | 220.00K | |||
| TOTAL ASSETS | 160.26M | 96.72M | 33.03M | 59.03M | 68.96M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.02M | 5.24M | 4.10M | 1.49M | 1.15M | |||
| Accounts Payable | 1.43M | 186.00K | 1.13M | 760.00K | 510.00K | |||
| Other Current Liabilities | 5.00K | 233.00K | 60.00K | 190.00K | 240.00K | |||
| Total Current Liabilities | 4.45M | 5.65M | 5.28M | 2.44M | 1.91M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 10.00K | 10.00K | |||
| Other Non-Current Liabilities | N/A | 0.00 | 80.00K | 220.00K | 70.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 80.00K | 230.00K | 70.00K | |||
| TOTAL LIABILITIES | 4.45M | 5.65M | 5.36M | 2.67M | 1.98M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -295.31M | -249.74M | -221.87M | -191.37M | -166.93M | |||
| Additional Paid In Capital | 450.88M | 340.78M | 35.00M | 33.11M | 31.02M | |||
| Common Shares | 3.20K | 2.20K | 214.62M | 214.62M | 202.89M | |||
| Other Shareholders' Equity | 229.90K | 29.90K | -80.00K | 0.00 | N/A | |||
| Shares Outstanding | 32.20M | 22.90M | 21.55M | 21.55M | 21.55M | |||
| Tangible Book Value per Share | 4.84 | 3.98 | -8.68 | -7.34 | -6.31 | |||
| Total Shareholders' Equity | 155.81M | 91.06M | 27.67M | 56.36M | 66.98M | |||
| TOTAL LIABILITIES AND EQUITY | 160.26M | 96.72M | 33.03M | 59.03M | 68.96M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Current Ratio | 34.30 | 17.09 | 6.21 | 24.04 | 35.99 | |||
| Return On Assets (ROA) | -28.43% | -28.82% | -92.34% | -41.40% | -16.49% | |||
| Return On Equity (ROE) | -29.25% | -30.61% | -110.23% | -43.36% | -16.98% | |||
All data in USD , ROIC based on taxRate of 0.21